Estrella Immunopharma, Inc.

NasdaqCM:ESLA Stock Report

Market Cap: US$43.1m

Estrella Immunopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ESLA?
Owner TypeNumber of SharesOwnership Percentage
Institutions144,7210.398%
Individual Insiders975,6382.68%
General Public9,978,10327.4%
Private Companies25,277,83169.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.8%.

Top Shareholders

Top 14 shareholders own 72.57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
69.5%
Eureka Therapeutics, Inc.
25,277,831US$29.9m0%no data
0.82%
Cheng Liu
297,437US$352.1k0%no data
0.73%
Jiandong Xu
264,388US$313.0k0%no data
0.66%
Hong Zhang
240,481US$284.7k0%no data
0.4%
Victor Shum
144,443US$171.0k0%no data
0.16%
Geode Capital Management, LLC
58,214US$68.9k0%no data
0.11%
ATW SPAC Management LLC
40,000US$47.4k0%0.06%
0.079%
Vivien Chan
28,889US$34.2k0%no data
0.06%
The Vanguard Group, Inc.
21,684US$25.7k484%no data
0.027%
Maso Capital Partners Ltd
10,000US$11.8k0%0.01%
0.021%
BlackRock, Inc.
7,568US$9.0k0%no data
0.02%
Tower Research Capital Europe Limited
7,151US$8.5k28.4%no data
0.00021%
Bank of America Corporation, Asset Management Arm
78US$90.40%no data
0.00007%
JPMorgan Chase & Co, Brokerage and Securities Investments
26US$30.10%no data